Churg-Strauss syndrome: clinical presentation of eosinophilic vasculitis in a critically ill patient. A case report
DOI:
https://doi.org/10.24265/horizmed.2025.v25n2.19Keywords:
Eosinophilic Granulomatosis with Polyangiitis , Systemic Vasculitis , Eosinophilia , Skin Diseases , Multiple Organ FailureAbstract
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome,
is a rare systemic vasculitis affecting small- and medium-sized vessels. It is characterized by late-onset asthma, peripheral eosinophilia and multiorgan involvement, which may include respiratory, cutaneous, renal, neurological and hematological manifestations. Diagnosis is challenging due to clinical variability and overlapping manifestations with other inflammatory diseases.
We present the case of a 58-year-old woman with a history of hypertension and Class III obesity,
who was admitted to the emergency department with severe respiratory failure and a six-month
history of asthma. During her hospitalization, she developed marked hypereosinophilia, painless
cutaneous lesions compatible with vasculitis, acute renal impairment and thrombocytopenia
associated with a positive Coombs test. Despite negative c-ANCA and p-ANCA results, the diagnosis
of EGPA was made based on clinical findings and subsequently confirmed by histopathological
examination, which revealed eosinophil-rich inflammatory infiltrates. Treatment was provided
with corticosteroid pulses and immunosuppression with rituximab, achieving complete resolution
of the multisystemic manifestations and hospital discharge in stable condition. This case underscores the importance of prompt diagnosis in rare diseases such as EGPA, where clinical suspicion and early therapeutic intervention with corticosteroids and immunosuppressants are essential for successful treatment. It also highlights the need for a multidisciplinary approach in the management of such patients, particularly in critical care settings.
Downloads
References
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012
Revised International Chapel Hill Consensus Conference Nomenclature
of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. Disponible en:
https://doi.org/10.1002/art.37715
Trivioli G, Terrier B, Vaglio A. Eosinophilic granulomatosis with
polyangiitis: understanding the disease and its management.
Rheumatology. 2020;59(Suppl 3):84-94. Disponible en: https://doi.
org/10.1093/rheumatology/kez570
Vélez-Páez JL, Carranza J, Luis M, Avellanas Chavala. La anamnesis,
una herramienta diagnóstica poderosa en tiempos de medicina
tecnológica e inteligencia artificial. Análisis y reflexión de un
caso. Rev Bionatura. 2024;1(2):1–5. Disponible en: http://dx.doi.
org/10.70099/BJ/2024.01.02.3
White JPE, Dubey S. Eosinophilic granulomatosis with polyangiitis: A
review. Autoimmun Rev. 2023; 22(1):103219. Disponible en: https://
doi.org/10.1016/j.autrev.2022.103219
Anaev EK, Kniajeskaia N. Eosinophilic granulomatosis with
polyangiitis: diagnosis and treatment-related issues. Pulmonologiya.
;33(4):542-51. Disponible en: https://doi.org/10.18093/0869-
-2022-4118
Calle AM, Aguirre N, Ardila JC, Cardona R. DRESS syndrome: A literature
review and treatment algorithm. World Allergy Organ. 2023;16(3):1-
Disponible en: https://doi.org/10.1016/j.waojou.2022.100673
Furuta S; Iwamoto T; Nakajima H. Update on eosinophilic
granulomatosis with polyangiitis. Allergol Int. 2019;68(4):430–6.
Disponible en: https://doi.org/10.1016/j.alit.2019.06.004
Nguyen Y, Guillevin L. Eosinophilic Granulomatosis with Polyangiitis
(Churg-Strauss). Semin Respir Crit Care Med. 2018;39(4):471-81.
Disponible en: https://doi.org/10.1055/s-0038-1669454
Pagnoux C. Updates in ANCA-associated vasculitis. Eur J Rheumatol.
;3(3):122-33. Disponible en: https://doi.org/10.5152/
eurjrheum.2015.0043
Treccani M, Veschetti L, Patuzzo C, Malerba G, Vaglio A, Martorana D.
Genetic and Non-Genetic Contributions to Eosinophilic Granulomatosis
with Polyangiitis: Current Knowledge and Future Perspectives. Curr
Issues Mol Biol. 2024;46(7):7516-29. Disponible en: https://doi.
org/10.3390/cimb46070446
David C, Hamel Y, Smahi A, Diot E, Benhamou Y, Girszyn N, et al.
Identification of EPX Variants in Human Eosinophilic Granulomatosis
With Polyangiitis (Churg-Strauss). J Allergy Clin Immunol Pract.
;11(6):1960-3. Disponible en: https://doi.org/10.1016/j.
jaip.2023.02.019
Vaglio A, Moosig F, Zwerina J. Churg-Strauss syndrome: update on
pathophysiology and treatment. Curr Opin Rheumatol. 2012;24(1):24-
Disponible en: https://doi.org/10.1097/BOR.0b013e32834d85ce
Villa-Forte A. Eosinophilic granulomatosis with polyangiitis. Postgrad
med. 2023;35:52-60. Disponible en: https://doi.org/10.1080/00325
2022.2134624
Fijołek J, Radzikowska E. Eosinophilic granulomatosis with
polyangiitis – Advances in pathogenesis, diagnosis, and treatment.
Front Med. 2023;10:1145257. Disponible en: https://doi.org/10.3389/
fmed.2023.1145257
Durel CA, Sinico RA, Teixeira V, Jayne D, Belenfant X, Marchand-
Adam S, et al. Renal involvement in eosinophilic granulomatosis with
polyangiitis (EGPA): a multicentric retrospective study of 63 biopsyproven
cases. Rheumatology. 2021;60(1):359-65. Disponible en:
https://doi.org/10.1093/rheumatology/keaa416
Nguyen QH, Tran HTT, Nguyen NM. A fatal eosinophilic granulomatosis
with polyangiitis case presenting intracerebral hemorrhage and
thrombocytopenia. J Allergy Clin Immunol Glob. 2023;2(4):100148.
Disponible en: https://doi.org/10.1016/j.jacig.2023.100148
Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA,
et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with
Polyangiitis. N Engl J Med. 2017;376(20):1921-32. Disponible en:
https://doi.org/10.1056/NEJMoa1702079
Tabb ES, Duncan LM, Nazarian RM. Eosinophilic granulomatosis with
polyangiitis: Cutaneous clinical and histopathologic differential
diagnosis. J Cutan Pathol. 2021;48(11):1379-86: Disponible en:
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).